🇺🇸 FDA
Pipeline program

Anastrozole

CDR0000448616

Phase 3 small_molecule active

Quick answer

Anastrozole for Breast Cancer is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 2 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Breast Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials